In conclusion, the present results suggest that Fol-PEG-α-CDE (G3, DSC2.4, DSF4, DSP4) could potentially be used as an FR-overexpressing cancer cell-selective siRNA delivery carrier in vitro and in vivo [80]. The gene discussed is DUSP26; the disease is cancer.